Telavic (Telaprevir)


Combined with:

Allopurinol
Loxonin
Peg-Intron
Peginterferon Alfa-2B
Rebetol
Ribavirin
Urso 250

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 98.4%
Adverse Event 0.3%
Hyperuricaemia 0.3%
Arrhythmia 0.1%
Hypertension 0.1%
Prophylaxis 0.1%
Musculoskeletal Pain 0.1%
Insomnia 0.1%
Product Used For Unknown Indication 0.1%
Blood Uric Acid Increased 0.0%
Face Oedema 0.0%
Hepatitis 0.0%
Nausea 0.0%
Sedation 0.0%
Viith Nerve Paralysis 0.0%
Cholelithiasis 0.0%
Cough 0.0%
Crohn's Disease 0.0%
Drug Eruption 0.0%
Unevaluable Event 0.0%
Rash 11.9%
Anaemia 8.2%
Neutrophil Count Decreased 8.2%
Decreased Appetite 8.0%
White Blood Cell Count Decreased 7.9%
Renal Impairment 7.4%
Drug Eruption 6.5%
Haemoglobin Decreased 6.1%
Blood Creatinine Increased 4.7%
Erythema Multiforme 4.4%
Renal Disorder 3.6%
Malaise 3.4%
Platelet Count Decreased 3.1%
Erythema 2.9%
Hyperuricaemia 2.9%
Nausea 2.6%
Pyrexia 2.3%
Retinopathy 2.2%
Blood Uric Acid Increased 1.8%
Toxic Skin Eruption 1.8%
Secondary
Hepatitis C 98.5%
Hypertension 0.5%
Hyperuricaemia 0.2%
Prophylaxis 0.2%
Adverse Event 0.2%
Insomnia 0.1%
Product Used For Unknown Indication 0.1%
Nausea 0.1%
Sedation 0.1%
Drug Eruption 0.0%
Face Oedema 0.0%
Anaemia 12.1%
White Blood Cell Count Decreased 11.7%
Decreased Appetite 11.0%
Haemoglobin Decreased 8.8%
Renal Impairment 7.4%
Rash 6.8%
Platelet Count Decreased 4.7%
Renal Disorder 4.6%
Blood Creatinine Increased 4.3%
Hyperuricaemia 3.8%
Neutrophil Count Decreased 3.8%
Erythema Multiforme 3.2%
Drug Eruption 3.1%
Malaise 3.1%
Nausea 2.7%
Erythema 2.4%
Retinopathy 2.3%
Pyrexia 1.5%
Retinal Haemorrhage 1.5%
Depression 1.4%

Drug Data